Further research is essential to fully comprehend the implications of increased PD-L1 expression and its availability in treating GVHD and autoimmune diseases, and in the context of organ transplantation, potentially promoting immune tolerance [87,88]. The gene discussed is CD274; the disease is graft versus host disease.